Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998

This publication has 25 references indexed in Scilit:

• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999
• Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
  AIDS, 1998
• Metabolic abnormalities and use of HIV-1 protease inhibitors
  The Lancet, 1998
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
  AIDS, 1998
• Visceral abdominal-fat accumulation associated with use of indinavir
  The Lancet, 1998
• Changes in AIDS incidence for men who have sex with men, United States 1990–1995
  AIDS, 1997
• A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
  New England Journal of Medicine, 1995
• Plasma lipids in HIV‐infected patients: a prospective study in 95 patients
  European Journal of Clinical Investigation, 1994
• Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
  Journal of Clinical Endocrinology & Metabolism, 1992
• Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
  The American Journal of Medicine, 1991